FUSION PHARMACEUTICALS INC's ticker is FUSN and the CUSIP is 36118A100. A total of 41 filers reported holding FUSION PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,513,535 | -3.2% | 582,129 | +74.0% | 0.00% | 0.0% |
| Q2 2023 | $1,563,570 | +106193.0% | 334,577 | -17.1% | 0.00% | 0.0% |
| Q1 2023 | $1,471 | -94.9% | 403,788 | +3344.7% | 0.00% | – |
| Q2 2022 | $29,000 | -86.4% | 11,722 | -56.5% | 0.00% | – |
| Q3 2021 | $213,000 | +85.2% | 26,925 | +151.0% | 0.00% | – |
| Q1 2021 | $115,000 | -78.9% | 10,726 | -76.9% | 0.00% | – |
| Q4 2020 | $546,000 | -75.1% | 46,510 | -74.5% | 0.00% | -100.0% |
| Q3 2020 | $2,196,000 | -40.3% | 182,712 | -13.2% | 0.00% | -40.0% |
| Q2 2020 | $3,677,000 | – | 210,501 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ADAMS STREET PARTNERS LLC | 2,973,744 | $24,028,000 | 4.99% |
| Pivotal bioVenture Partners Investment Advisor LLC | 1,598,377 | $12,613,000 | 4.97% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,670,516 | $29,658,000 | 3.03% |
| Sio Capital Management, LLC | 266,107 | $2,150,000 | 0.53% |
| Orbimed Advisors | 3,224,770 | $26,056,000 | 0.26% |
| Perceptive Advisors | 3,550,334 | $28,686,000 | 0.19% |
| AlphaCentric Advisors LLC | 71,500 | $578,000 | 0.16% |
| Rock Springs Capital Management LP | 948,327 | $7,662,000 | 0.15% |
| TPG Group Holdings (SBS) Advisors, Inc. | 2,551,794 | $20,618,000 | 0.15% |
| Artal Group S.A. | 750,000 | $6,060,000 | 0.12% |